About this test
Genotypes the 4G/5G promoter polymorphism of the PAI-1 (SERPINE1) gene, which influences PAI-1 levels and fibrinolysis. Its clinical value for thrombosis risk is limited, so it is offered on request rather than as a routine test.
Fibrinolysis, research and selected work-ups
Genotypes the 4G/5G promoter polymorphism of the PAI-1 (SERPINE1) gene, which influences PAI-1 levels and fibrinolysis. Its clinical value for thrombosis risk is limited, so it is offered on request rather than as a routine test.
When requested by the treating clinician, usually alongside Factor V Leiden and prothrombin testing.
Offered on request. Current guidelines give this test a limited role in routine practice; results are reported as genotype or expression data for the ordering clinician to interpret.
Results are reported to the ordering physician and should be interpreted in clinical context.
Contract pricing and turnaround times are provided on request for laboratories and clinics.